Man Group
ANIP icon

Man Group’s ANI Pharmaceuticals ANIP Stock Holding History

Man Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.66M Sell
80,496
-128,198
-61% -$10.3M 0.01% 984
2026
Q1 		$16M Buy
208,694
+127,961
+158% +$9.99M 0.03% 598
2025
Q4 		$6.37M Buy
80,733
+45,944
+132% +$3.98M 0.01% 990
2025
Q3 		$3.19M Buy
34,789
+2,034
+6% +$166K 0.01% 1242
2025
Q2 		$2.14M Buy
+32,755
New +$2.13M ﹤0.01% 1386
2024
Q4 		– Sell
-14,175
Closed -$846K – 1981
2024
Q3 		$846K Buy
14,175
+7,855
+124% +$479K ﹤0.01% 1539
2024
Q2 		$402K Sell
6,320
-1,087
-15% -$70.6K ﹤0.01% 1734
2024
Q1 		$512K Buy
7,407
+2,315
+45% +$140K ﹤0.01% 1772
2023
Q4 		$281K Buy
+5,092
New +$280K ﹤0.01% 1831
2021
Q1 		– Sell
-71,090
Closed -$2.06M – 1845
2020
Q4 		$2.06M Sell
71,090
-11,600
-14% -$332K 0.01% 1191
2020
Q3 		$2.33M Buy
82,690
+21,886
+36% +$652K 0.01% 1144
2020
Q2 		$1.97M Sell
60,804
-9,278
-13% -$333K 0.01% 1073
2020
Q1 		$2.85M Sell
70,082
-43,012
-38% -$2.29M 0.02% 726
2019
Q4 		$6.97M Buy
113,094
+28,100
+33% +$1.86M 0.02% 862
2019
Q3 		$6.19M Buy
+84,994
New +$6.36M 0.02% 779
2018
Q4 		– Sell
-8,338
Closed -$471K – 1905
2018
Q3 		$471K Buy
8,338
+5,306
+175% +$325K ﹤0.01% 1854
2018
Q2 		$203K Buy
+3,032
New +$189K ﹤0.01% 2011

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group's ANIP Position: Q2 2026 in Review

Man Group reduced its ANI Pharmaceuticals (ANIP) stake by 61% in Q2 2026, selling an estimated $10.3M and leaving 80,496 shares worth $6.66M. The position accounts for 0.01% of the portfolio, ranked #984.

Man Group first reported a position in ANIP in Q2 2018 and has held it in 17 quarters since. The position peaked at $16M in Q1 2026. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Man Group held 80,496 shares of ANI Pharmaceuticals worth $6.66M as of Q2 2026.
  • Man Group sold 128,198 ANI Pharmaceuticals shares in Q2 2026, an estimated $10.3M.
  • ANI Pharmaceuticals made up 0.01% of Man Group's portfolio in Q2 2026, its #984 holding.
  • Man Group first reported a position in ANI Pharmaceuticals in Q2 2018 and has held it in 17 quarters since.
  • Man Group's ANI Pharmaceuticals position peaked at $16M in Q1 2026.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.